Nippon Life India Asset Management Limited (NAM-INDIA.NS)
Mumbai, IN
Nippon Life Asset Management Limited operates as a publicly traded investment management organization. The firm specializes in creating and overseeing a diverse range of investment vehicles for its clients, including equity and fixed-income mutual funds, as well as exchange-traded funds (ETFs). Its capital allocation strategies focus on public equity, fixed income, and commodity markets. This entity, based in Mumbai, India, was founded on February 24, 1995, and was previously known as Reliance Nippon Life Asset Management Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.02% | +0.44% | +8.92% | +18.13% | +25.63% | +25.05% | +48.47% | +340.44% | +196.90% | +286.78% | +286.78% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 6 | 0 |
| Buy | 13 | 0 |
| Hold | 4 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth+53.4% Q1'26: +24.5% (vs Q1'25)
-
EPS growth+14.3% Q1'26: +27.5% (vs Q1'25)
-
FCF margin+54.8% Q1'26: +78.0% (vs Q1'25)
-
EBIT margin+67.5% Q1'26: +65.2% (vs Q1'25)
-
ROIC+74.3% Q1'26: +34.7% (vs Q1'25)
-
Share dilution+1.7% Q1'26: +1.0% (vs Q1'25)
-
Debt / EBITDA0.05× Q1'26: 0.04× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 15 Rev. Ana. 19 EPS Ana. |
Mar 2027 16 Rev. Ana. 21 EPS Ana. |
Mar 2028 16 Rev. Ana. 21 EPS Ana. |
Mar 2029 7 Rev. Ana. 9 EPS Ana. |
Mar 2030 3 Rev. Ana. 3 EPS Ana. |
Mar 2031 5 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
15.92B
est: 17.42B (-8.6%)
|
14.79B
est: 15.97B (-7.4%)
|
12.03B
est: 11.99B (+0.3%)
|
10.62B
est: 12.51B (-15.1%)
|
13.07B
est: 14.21B (-8.0%)
|
13.50B
est: 14.36B (-6.0%)
|
16.43B
est: 22.02B (-25.4%)
|
22.31B
est: 23.61B (-5.5%)
|
28.04B
26.31B – 29.99B
+18.8% YoY
|
32.78B
29.94B – 35.26B
+16.9% YoY
|
38.54B
33.93B – 41.59B
+17.6% YoY
|
46.26B
46.26B – 46.27B
+20.0% YoY
|
54.29B
48.62B – 58.50B
+17.3% YoY
|
62.97B
56.39B – 67.85B
+16.0% YoY
|
| EBITDA |
6.66B
est: 13.53B (-50.8%)
|
5.38B
est: 7.78B (-30.9%)
|
5.99B
est: 6.70B (-10.7%)
|
9.15B
est: 5.46B (+67.6%)
|
10.20B
est: 6.06B (+68.3%)
|
9.62B
est: 7.22B (+33.2%)
|
13.88B
est: 16.74B (-17.1%)
|
17.32B
est: 17.60B (-1.6%)
|
21.31B
20.00B – 22.80B
+21.1% YoY
|
24.91B
22.75B – 26.80B
+16.9% YoY
|
29.29B
25.79B – 31.61B
+17.6% YoY
|
35.16B
35.16B – 35.16B
+20.0% YoY
|
41.26B
36.95B – 44.46B
+17.3% YoY
|
47.86B
42.86B – 51.57B
+16.0% YoY
|
| EBIT |
6.58B
est: 13.17B (-50.1%)
|
5.28B
est: 4.83B (+9.4%)
|
5.65B
est: 4.03B (+40.4%)
|
8.81B
est: 5.33B (+65.4%)
|
9.92B
est: 5.92B (+67.8%)
|
9.32B
est: 7.05B (+32.2%)
|
13.59B
est: 16.35B (-16.9%)
|
17.01B
est: 13.00B (+30.9%)
|
20.82B
19.53B – 22.27B
+60.2% YoY
|
24.33B
22.23B – 26.18B
+16.9% YoY
|
28.61B
25.19B – 30.87B
+17.6% YoY
|
34.35B
34.34B – 34.35B
+20.0% YoY
|
40.30B
36.10B – 43.43B
+17.3% YoY
|
46.75B
41.87B – 50.37B
+16.0% YoY
|
| Net Income |
4.56B
est: 5.31B (-14.2%)
|
4.86B
est: 4.40B (+10.4%)
|
4.15B
est: 3.71B (+12.0%)
|
6.80B
est: 3.89B (+74.9%)
|
7.44B
est: 4.32B (+72.4%)
|
7.23B
est: 8.45B (-14.4%)
|
11.07B
est: 12.04B (-8.0%)
|
12.86B
est: 13.50B (-4.7%)
|
15.29B
14.13B – 16.10B
+13.3% YoY
|
17.87B
15.12B – 20.41B
+16.9% YoY
|
21.12B
19.50B – 24.56B
+18.2% YoY
|
24.72B
23.10B – 28.56B
+17.0% YoY
|
30.61B
26.46B – 33.70B
+23.9% YoY
|
34.95B
30.21B – 38.47B
+14.2% YoY
|
| SGA |
5.05B
est: 1.08B (+365.8%)
|
3.82B
est: 7.43B (-48.6%)
|
1.25B
est: 5.12B (-75.6%)
|
683.60M
est: 4.90B (-86.0%)
|
779.60M
est: 5.44B (-85.7%)
|
881.50M
est: 6.48B (-86.4%)
|
1.24B
est: 1.14B (+8.8%)
|
1.31B
est: 1.20B (+8.9%)
|
1.45B
1.36B – 1.55B
+21.1% YoY
|
1.70B
1.55B – 1.83B
+16.9% YoY
|
2.00B
1.76B – 2.16B
+17.6% YoY
|
2.40B
2.40B – 2.40B
+20.0% YoY
|
2.81B
2.52B – 3.03B
+17.3% YoY
|
3.26B
2.92B – 3.52B
+16.0% YoY
|
| EPS |
7.63
est: 8.28 (-7.8%)
|
7.94
est: 7.89 (+0.6%)
|
6.78
est: 6.86 (-1.2%)
|
11.04
est: 10.50 (+5.1%)
|
12.00
est: 11.97 (+0.3%)
|
11.61
est: 11.47 (+1.3%)
|
17.71
est: 19.20 (-7.8%)
|
20.34
est: 20.14 (+1.0%)
|
23.33
21.84 – 24.87
+15.8% YoY
|
27.33
23.36 – 31.53
+17.1% YoY
|
32.39
30.13 – 37.95
+18.5% YoY
|
38.42
35.69 – 44.13
+18.6% YoY
|
47.30
40.88 – 52.07
+23.1% YoY
|
54.00
46.67 – 59.44
+14.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-25 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-15 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-14 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-13 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-12 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-11 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-07 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-06 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-05 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-04 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-29 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-13 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-10 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Sundeep Sikka | MD, CEO & Executive Nominee Director | 287M | male |
| Parag Joglekar | Chief Financial Officer | 18M | male |
| Arash Arethna | Lead of Investor Relations | — | male |
| Kaiyomurz Daver | Chief Marketing Officer | — | male |
| Milind Nesarikar | Chief Officer of Operations & Customer Service? | — | male |
| Muneesh Sud | General Counsel & Chief of Compliance | — | male |
| Rajesh Derhgawen | Chief Human Resources Officer | — | male |
| Sailesh Raj Bhan | President & Chief Investment Officer of Equity Investments | — | male |
| Sanjiv Gudal | Head of Retail Business Development and Rural & Emerging Markets Group | — | male |
| Saugata Chatterjee | Deputy CEO, President and Chief Business Officer of Sales, Distribution & Operations | — | male |
| Abhijit Shah | Chief Technology Officer | — | male |
| Sunil Singhania | Chief Investment Officer of Equity Investments | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NAM-INDIA.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
